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ABSTRACT

Antimicrobial and Anticancer Activity of
Essential oils from Guatemalan
Medicinal Plants

Andrew B. Miller
Department of Biology
Master of Science

Guatemalan medicinal plants were collected and screened for the presence of essential oils using
steam distillation. Oil was found in 63 species from 24 families and was tested in tube dilution
assays for activity against Escherichia coli, Staphylococcus aureus, Streptococcus mutans,
Lactobacillus acidophilus and Candida albicans. Several essential oils were highly active with
20 instances of oils inhibiting the microbes at an MIC of 0.31 μl/ml. Oils were also tested against
cancerous and established cell lines using a 15% (v/v) agar-media which was developed to
improve essential oil solubility. Assays were performed against three cancer lines: Stomach
(AGS: CRL-1739), Skin (A375: CRL-1619), Tongue (CAL27: CRL-2095) and an established
Monkey Kidney cell line (Vero C 1008: CRL-1586). Assessment of viability was performed
using the Neutral Red assay with results indicating that many of the oils significantly inhibited
cancer cell lines in vitro with 24 individual instances producing an IC50 of 0.20 μl/ml or less.
Therapeutic indices indicated that many of the highly inhibitory oils were more cytotoxic to
cancerous cell lines than to the established cell line.

Key words: Guatemala, medicinal plant, essential oil, Escherichia coli, Staphylococcus aureus,
Streptococcus mutans, Lactobacillus acidophilus, Candida albicans, MIC, solubility,
cytotoxicity, cancer, stomach, AGS, skin, A375, tongue, CAL27, Vero C 1008, neutral red, IC50,
therapeutic index, Origanum vulgare, Lippia graveolens, Citrus aurantiifolia
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CHAPTER I
The Importance of Essential Oils in the Search for
New Drugs

Introduction
Successful plant remedies and their preparations as medicinal treatments have been used for
thousands of years in indigenous cultures around the world (Balunas & Kinghorn, 2005). Many
of these traditionally used plants have been scientifically evaluated with results yielding today’s
valuable drugs such as asprin, digitoxin, morphine and quinine (Butler, 2004). In most
developing countries plants are still relied upon as the primary source of medical treatment due
to the cost of prepared medicines. It is estimated that over 65% of the world population relies
directly on plants as their main source of medicine (Fabricant & Farnsworth, 2001) with 75-90%
of the world’s rural communities relying primarily on plants (Fowler, 2006). The WHO reports
that 80% of the people of Africa, 40% of the people of China and Asia, and 40% of the people of
South America use medicinal plants as their primary care (WHO, 2002). Much of the scientific
effort of the past few decades with medicinal plants has focused on documenting the uses of
traditional medicine, analyzing the effectiveness of particular remedies, chemically
characterizing medicinal plant compounds, and testing plant compounds in vitro (Fabricant &
Farnsworth, 2001; Butler, 2004; Balunas & Kinghorn 2005; Fowler, 2006; Gertch, 2009). Based
on the past history of success in finding new compounds, additional valuable discoveries will be
made (Fabricant & Farnsworth, 2001; Butler, 2004; Newmann & Cragg, 2007).

Essential oils are common in plants that are used traditionally as medicinal treatments (Edris,
2007) and currently are more systematically studied (Kalemba & Kunicka, 2003; Lalou, 2004).
1

Recent literature indicates that essential oils have been tested for activity against many types of
organisms known to cause human disease (Boyon et al., 2003; Kalemba & Kunicka, 2003;
Lalou, 2004; Anthony, 2005; Edris, 2007) as well as for activity against cancer cell lines (Edris,
2007).

Essential oils are known to be complex mixtures of monoterpenes, sesquiterpenes, and volatile
phenolics (Carson & Riley 1995), as well as alcohols, aldehydes, ethers, hydrocarbons and
ketones (Kalemba & Kunica, 2003). Synergism has been demonstrated to be an accurate
explanation of oil bioactivity (Wittstock & Gershenzon, 2002; Savelev et al., 2003; Burt, 2004).
The level of activity is dependent on the combination and ratio of different components as
opposed to quantity of the primary constituent (Kalemba & Kunica, 2003; Houghton et al.,
2007). Phenols have been credited as being the most active components with the broadest
spectrum of antimicrobial activity followed by aldehydes, keytones and alcohols (Kalemba &
Kunica, 2003).

Due to high levels of poverty, health care options in rural Guatemala are limited (Goldman et al.
2002). Consequently, rural impoverished individuals choose local experts, who are familiar with
traditional healing and plant-based remedies, for treatments (Booth et al., 1993; Goldman et al.,
2002; Kufer et al. 2005, Hautecoeur et al. 2007). Many of the plants are prepared for use in teas
through decoction or infusion, which are methods shown to extract essential oils and their
components (Carnat et al., 1999; Billia et al., 2000; Radulescu et al., 2004). However, most of
the commonly used plants have not been thoroughly analyzed, leaving potential bioactivity
undocumented (Kufer et al., 2005).
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The evidence in these recently published research findings indicate that essential oils and their
components have potential to be valuable resources in the production of new drugs useful against
human diseases and for cancer chemotherapy. Consequently, this study was undertaken to
examine the activity of essential oils from many commonly used Guatemalan medicinal plants
against bacteria, a fungus, and several cancer cell lines. The activity displayed in these bioassays
will demonstrate the effectiveness of these essential oils through their production of highly
inhibitory MIC and IC50 values, indicating their potential for development into useful drugs and
compounds.
.
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CHAPTER II
The Antibacterial and Antifungal Activity of Essential Oils Obtained
from 64 Guatemalan Medicinal Plants
Introduction
Fragrant and aromatic plants comprise a large portion of the species that have historically been
used in traditional medicine (Edris, 2007). These plants typically contain essential oils which
have become the focus of many recent studies (Kalemba & Kunicka, 2003; Lahlou, 2004).
Essential oils have been tested for bioactivity against bacteria (Edris, 2007), fungi (Kalemba &
Kunicka, 2003), parasitic protozoans (Boyom et al., 2003; Anthony, 2005), viruses (Edris, 2007),
and cancer cell lines (Edris, 2007), all of which indicate that there is potential for the
development of new compounds for drugs.

Due to the level of poverty in Guatemala, health care options in rural areas are limited (Goldman
et al., 2002). There is little access to medical heath clinics, and family income can be a major
constraint on health care (Goldman et al., 2002; Hautecoeur et al., 2007). As a result, many
villagers from rural communities choose to see non-biomedical health practitioners (Goldman et
al., 2002) or choose to rely on local knowledge of medicinal plants as solutions to health
concerns (Booth et al., 1993; Kufer et al., 2005). Many commonly used plants of Guatemala
have been insufficiently studied, leaving an incomplete picture of general phytochemical and
pharmacological activities (Kufer et al., 2005).

Consequently, the objectives of this study included the determination, from a selected group of
plants, of species containing essential oils and the distribution of these oils across plant families.
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Secondly, those plants containing sufficient essential oils were bioassayed to determine their
level of activity against Staphylococcus aureus, Streptococcus mutans, Escherichia coli,
Lactobacillus acidophilus, and the yeast Candida albicans. The resulting MIC (minimum
inhibitory concentration) data would be useful in increasing understanding about the medicinal
plants that are commonly used by rural villagers and provide preliminary data for future studies.

Materials and Methods
Plant tissue collection
Commonly used medicinal plants were collected in Guatemala from 2007 to 2009. Berny Danilo
Gálvez and Carlos Enrique Ardón collected plants in the Chiquimula Department in the villages
of Tuticopote Abajo, Salitrón, and Roblarcito of the Torjá River basin, and in San Francisco
Chancó of the Chancó River basin in the municipalities of Olopa and San Juan Ermita.
Additional collections were made in Guatemala City by Dr. Ivan Rodríguez and Rex Cates at the
Museo Odontológico de Guatemala and the Jardín Botánico Maya, by Luis Espinoza and R.
Cates in the Pinalito association, and by Alfonso Fuentes and Dany Arbizu in the medicinal plant
gardens at the University of San Carlos, Guatemala City, Guatemala.

Each sample was individually numbered and bagged and placed in a cooler on dry ice. Voucher
specimens were collected and are stored in the Natural Products Laboratory at Brigham Young
University Provo, UT and the herbarium at the University of San Carlos, CUNORI Campus,
Chiquimula, Guatemala (Table 1). Collected samples were then stored in a freezer until shipped
on dry ice to the Natural Products Laboratory in Provo, Utah and stored at -80o C until analyzed.
Tissue types varied between leaf, root, seed and aerial portions to whole plants. Species were
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identified by the taxonomists Jose Vicente Martínez Arvevalo, Mario Esteban Véliz Perez, and
Marco Romilio Estrada Muy using voucher specimens and in some instances, vouchers and
digital photographs.
Essential oil extraction and preparation
A steam distillation apparatus (Scientific-Glass, Rancho Santa Fe, CA, USA) was used to extract
essential oils (Luque de Castro, 1999). In order to determine the general chemical content of
these extracts, preliminary samples were extracted and analyzed by GC-MS (HP model
6890/5973, Agilent Technologies Inc., Santa Clara, CA, USA). Commonly found in these
extracts were monoterpenes, diterpenes, sesquiterpenes and other volatile compounds routinely
extracted by steam distillation. Prior to distillation, fresh plant tissue was weighed and cut into ½
inch sized pieces. 50g of tissue was used for each extraction and steam distillation was conducted
at 315o C for 3½ hours. Root and seed samples were first ground in liquid nitrogen using 125g of
tissue followed by steam distillation at 315o C for 8 hours.

Essential oils were removed from the distillation apparatus receiver by pipette. To aid in the
separation of oils from the water and glass surfaces, 125μl of diethyl-ether (Mallinckrodt-Baker,
Phillipsburg, NJ, USA) was added to the receiver. The oil/diethyl-ether mixture was removed,
placed in vials and dehydrated using anhydrous sodium sulfate (EMD Chemicals, Darmstadt,
Germany). To separate the oils from the sodium sulfate, 200μl of additional diethyl-ether was
added. The dehydrated oil/diethyl-ether mixture was evaporated under pressurized nitrogen to
remove all traces of diethyl-ether (approx. 35 seconds). The final product of purified essential oil
was then placed in an amber vial, weighed and stored at -80o C until bioassayed.
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Determination of minimum inhibitory concentration (MIC)
The microbes chosen for bioactivity testing were Escherichia coli (ATCC 11229; ATCC,
Manassas, VA, USA), Staphylococcus aureus (ATCC 6538P; Becton Dickinson Laboratories,
Cockeysville, MD, USA), Streptococcus mutans (ATCC 33402; ATCC), Lactobacillus
acidophilus (ATCC 11975; ATCC) and Candida albicans (ATCC 90028; ATCC).

The tube dilution assay with slight modification (Donaldson et al., 2005) was selected as the
method for determining the minimum inhibitory concentration (MIC). Two percent agar (w/v)
added to broth was used to reduce essential oil volatility and increase solubility (Donaldson et
al., 2005). E. coli, S. aureus and S. mutans were cultured in Tryptic Soy broth (Becton,
Dickinson and Co.), L. acidophilus in MRS broth (Becton, Dickinson and Co.) and C. albicans
in Sabbaraud Dextrose broth (Sigma-Aldrich, St. Louis, MO, USA). S. mutans and L.
acidophilus were incubated in a 5% CO2 atmosphere at 37o C while E. coli, S. aureus and C.
albicans were incubated at 37o C in natural air.

Serial dilutions were used to prepare a series of five borosilicate glass test tubes (13 x 100 mm)
for each trial. The initial tube was filled with 4ml of agar-broth and 20μl of essential oil was
added. The mixture was vortexed and 2ml was removed and placed into a second tube containing
2ml of agar-broth. This process was repeated to create five dilutions with oil concentrations of
5.00μl/ml, 2.50μl/ml, 1.25μl/ml, 0.63μl/ml and 0.31μl/ml. Each test tube was inoculated with
20μl of microbial broth. Controls for each microbe consisted of two tubes, one receiving no
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treatment and the other receiving 20μl of the microbial broth without the addition of oil. All
tubes were incubated for 24 hours at 37oC.

After 24 hours, 800μl of iodonitrotetrazolium chloride dye solution (INT) (Sigma-Aldrich) were
added to each tube. INT is a colorimetric indicator that changes from clear to purple after
exposure to CO2 indicating bacterial respiration, metabolic activity and growth (Mann &
Markham, 1998; Donaldson et al., 2005). A concentration of 20mg/ml was used for E. coli and S.
aureus and 125mg/ml for C. albicans. Color change results were observed after 30 minutes.
Samples of all tubes that did not exhibit a color change were plated on agar plates to confirm the
inhibition of growth. All controls were also plated to confirm the positive results of growth
indicated by the INT color change. INT was not used for S. mutans or L. acidophilus as results
were unreliable due to indistinct color changes. Samples of all tubes of S. mutans and L.
acidophilus were plated.

Bacterial plates were incubated for 24 hours at 37oC and then each plate was examined for
growth and validation of the INT results. The concentration that inhibited the bacteria was
identified and the resultant MIC recorded with the MIC being defined as the lowest
concentration of essential oil capable of inhibiting greater than 95% of the growth of the
microorganism.

Two positive control drugs were used to verify assay repeatability and provide a comparison for
the MIC values derived from the tested essential oils (Hoffmann et al., 1993; McCutcheon et al.,
1994; Ritch-Krc et al., 1996). Gentamycin (10mg/ml) was used against E. coli, S. aureus, S.
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mutans and L. acidophilus, and nystatin (1mg/ml in DMSO) used against C. albicans. 20μl of
these drugs were administered and diluted following the same procedure used for essential oils.
All control and experimental groups for all assays were replicated three times.

Results
Number of species with essential oils and their average yield
Of the 141 plant species screened for essential oil content, 63 (45%) produced sufficient oil for
collection (Table 1). Forty six (73%) of these produced an average yield of less than 0.2 %
(w/w). Nine and five species yielded 0.2% - 0.4% and 0.4% - 0.6%, respectively, two species
yielded 0.6% - 1.0%, and one species yielded over 1.0%.

Of the 63 plants that produced collectible oil, 51 (81%) produced sufficient oil quantity to be
used in the bioassay. Of those oils tested, 34 (54%) demonstrated activity against at least one
organism (Table 2). Thus, 24% of the 141 species collected showed activity against one or more
microbes.

Twelve species were not tested due to low oil yield (Table 2). Seven species were not active
against the one or two microbes they were tested against, and due to lack of oil were not tested
on additional microbes (Table 2).
Essential oil activity as determined by MIC
A highly inhibitory MIC was 0.31μl/ml with no variation among replicates in the range of MIC
values. Thirteen species recorded a highly inhibitory MIC as observed in 20 bioassays (25% of
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all MIC values) (Table 2). Another 18 species displayed a moderately inhibitory MIC, between
0.31 and 0.63μl/ml, in 20 bioassays (25% of all MIC values). An additional 18 bioassays (22%)
from 14 species produced an MIC that was neither highly or moderately inhibitory but had an
MIC more inhibitory than the reference drug (Table 2). Overall, 58 (72%) of the recorded MIC
values were lower than those of the known reference drugs.

S. mutans had the most highly inhibitory MIC values and was the microorganism most inhibited
based on the number of essential oils showing activity against it (72%) (Table 2). L. acidophilus
was second most likely to be inhibited with 56% of all tests showing activity, although none of
the MIC values recorded reached a highly inhibitory level. C. albicans was the third most likely
with 48% showing inhibition followed by S. aureus with 28%. E. coli was the most resistant
organism with only a 19% susceptibility rate.

E. coli was the microbe with the most inhibitory MIC value as averaged across all oil trials
(0.86μl/ml), indicating that when inhibited, the level of inhibition was high (Table 2). S. mutans
was the second most inhibited at 0.92μl/ml followed by 0.99μl/ml for C. albicans, 1.77μl/ml for
S. aureus, and 2.05μl/ml for L. acidophilus.
Family distribution of species containing essential oil
Oils were collected from 24 individual families with nine families being represented by more
than one species (Table 3). 24% of all species with oil were from Asteraceae, 11% from
Lamiaceae, 9% from Rutaceae and 8% from Verbenaceae. These four families accounted for
52% of all species that produced an essential oil.
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Of the nine families represented by more than one species, six families had multiple species
producing MIC values, but only three families had more than one species with a highly
inhibitory MIC value (0.31μl/ml) (Table 3). One species was collected from each of the families
Bixaceae, Myricaceae and Vitaceae, and each specimen produced a highly inhibitory MIC.
Eleven families had MIC values that were moderately inhibitory (between 0.31-0.63μl/ml) to at
least one microbe (Table 3). Also, potential specificity of a species against a microbe is indicated
since five families produced a species that was highly inhibitory to at least one microbe species.

Discussion
Number of species with essential oils and their average yield
Several species examined in this study have not previously been reported as having essential oils
(Table 2). Essential oil has been reported from the fruits of Spondias purpurea (Koziol & Macia,
1998), but has not been reported from the leaves which were used in this study. Oils of Arnica
montana, Buddleja americana, Tagetes lucida, Tagetes filifolia, Pluchea odorata, Cissus
verticillata, Ilex aquifolium, Cupressus lusitanica, Litsea guatemalensis, Piper auritum and
Spilanthes americana were active in this study but are not reported elsewhere as active against
the microbes tested here. Additionally, activity of tissue specific oils from the seeds of Bixa
orellana, the leaves of Citrus limetta, Citrus aurantium, and Citrus aurantiifolia, and the aerial
portions of Foeniculum vulgare are new contributions.
Essential oil activity as determined by MIC
Results of this study indicate that many of the oils have good antibacterial or antifungal potential
(Table 2). Several species in this study show high potential for future research. Origanum
vulgare and Lippia graveolens produced highly inhibitory MIC values for E. coli, S. mutans, S.
13

aureus and C. albicans and MIC values for L. acidophilus lower than those of the reference
drugs, indicating the ability of these oils to inhibit a variety of microbes at a high level. The oils
of these two species are reported to have similar compositions (Salguiero et al., 2003) which may
explain the similarity of results.

Sin Sin was highly inhibitory to S. mutans and S. aureus but not tested on other microbes due to
low yield. Citrus aurantiifolia and Cinnamomum zeylanicum were highly inhibitory against one
microbe and produced MIC values of moderate inhibition and lower than the reference drug for
three other microbes, indicating broad spectrum activity. Tagetes filifolia shows promise with
two MIC values of moderate inhibition and Mentha piperita also indicates potential with one
MIC of moderate inhibition and three MIC values below those of the reference drugs.

Teloxys ambrosioides exhibited specific activity against C. albicans, having one of the lower
MIC values but also a consistent range (Table 2). These results are supported by Jardim et al.,
(2008) who found a high level of inhibition for this oil against a number of fungi.
Family distribution of species containing essential oil
Essential oils have previously been reported from various species of each family tested in this
study (Lahlou, 2004; Bakkali et al., 2008). Some families and their species produced a higher
average MIC against specific microbes than other families (Table 4). Notable were the average
values of species from Lauraceae against S. mutans (.31μl/ml), Rutaceae against C. albicans
(0.36μl/ml), Lamiaceae against S. mutans (0.42μl/ml) and Asteraceae against E. coli (0.42μl/ml).
Oils from species of the same family (e.g. Rutaceae) are known to produce some of the same
compounds, increasing their likelihood of inhibiting particular microbes (Edris, 2007).
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Conclusion
Results of this study indicate that essential oils are common to plants that are used as traditional
medicines in Guatemala and are produced from many families. Most commonly, species with oil
are from Asteraceae, Lamiaceae, Rutaceae and Verbenaceae. Highly inhibitory MIC values were
reported for Origanum vulgare, Lippia graveolens, Citrus aurantiifolia, Sin Sin, Cinnamomum
zeylanicum and eight other species, many of which show potential for development based on
these values. Arnica montana, Buddleja americana, Tagetes lucida, Tagetes filifolia, Pluchea
odorata, Cissus verticillata, Ilex aquifolium, Cupressus lusitanica , Litsea guatemalensis, Piper
auritum and Spilanthes americana demonstrated activity not previously reported and several
were highly inhibitory to the microbes tested. High levels of inhibition were also observed across
species from the same family. These and other results indicate that essential oils can be highly
active against human microbial pathogens in vitro. In vivo testing is needed to determine if these
whole oils or their components can be developed into resources for the treatment of oral, gastric
and dermal infections and opportunistic fungal infections. Cytotoxicity data needs to be collected
for these oils to confirm their safety in drug development and in everyday use by those who rely
on these plants for traditional medicine.

Essential oils could be responsible for many of the positive health effects reported by users of
traditional medicine. A high percentage of traditional preparations involve teas created either by
decoction or infusion which are known methods for the extraction of essential oils and their
components (Carnat et al., 1999; Bilia et al., 2000; Radulescu et al., 2004). Additional
understanding needs to be gained about the role essential oils play in the effectiveness of
medicinal teas.
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Table 1. Species, family, common name, tissue type and mean oil yield per species for Guatemalan medicinal plants extracted by
steam distillation
Species

Family

Common Name

Tissue Type

X̄ Oil Yield
(%)

18

Achillea millefolium L.

Asteraceae

Milenrama

Aerial Portion

0.12

Ageratum sp.

Asteraceae

Violeta

Aerial Portion

0.04

Anacardium occidentale L.

Anacardiaceae

Marañon

Leaf

0.01

Arnica montana L.

Asteraceae

Árnica

Aerial Portion

0.07

Baccharis latifolia Pers.

Asteraceae

Conrrobo Negro

Aerial Portion

0.07

B. trinervis Pers.

Asteraceae

Corrimiento

Aerial Portion

0.11

Bixa orellana L.

Bixaceae

Achiote

Seed and Pod

0.03

Buddleja americana L.1

Buddlejaceae

Salvia Santa

Leaf

0.20

B. davidii Franch.

Buddlejaceae

Hoja de Lanza

Aerial Portion

0.07

Bursera simaruba Sarg.

Burseraceae

Palo de Jiote

Leaf

0.02

Casimiroa edulis La Llave

Rutaceae

Matasano

Leaf

0.02

Cinnamomum zeylanicum Blume

Lauraceae

Canela

Leaf

0.92

Cissus verticillata (L.) Nicolson & C.E.Jarvis 1

Vitaceae

Tabardillo

Aerial Portion

0.03

Citharexylum donnell-smithii Greenm. 1

Verbenaceae

Coralillo

Leaf

0.03

Citrus aurantiifolia (Christm.) Swingle

Rutaceae

Limón Criollo

Leaf

0.40
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C. aurantium L.

Rutaceae

Naranja

Leaf

0.06

C. limetta Risso

Rutaceae

Lima

Leaf

0.10

Clematis dioica L. 1

Ranunculaceae

Bejuco de Cancer

Aerial Portion

< .01

Croton sp.

Euphorbiaceae

Quina

Leaf

0.23

Cupressus lusitanica Mill.

Cupressaceae

Ciprés

Leaf

0.26

Cymbopogon citratus Stapf

Poaceae

Té Limón

Leaf

0.03

Elephantopus spicatus Aubl. 1

Asteraceae

Oreja de Coche

Aerial Portion

0.03

Eucalyptus sp.

Myrtaceae

Eucalipto

Leaf

0.46

Eupatorium semialatum Benth.

Asteraceae

Venadillo

Aerial Portion

0.04

Foeniculum vulgare Mill.

Apiaceae

Hinojo

Aerial Portion

0.14

Ilex aquifolium L.

Aquifoliaceae

Trueno

Leaf

0.02

Lantana camara L.

Verbenaceae

Cinco Negritos

Aerial Portion

0.05

Lippia dulcis Trevir.

Verbenaceae

Hierba Dulce

Aerial Portion

0.09

L. graveolens Kunth

Verbenaceae

Oregano

Leaf

0.47

Liquidambar styraciflua L.

Hamamelidaceae

Liquidambar

Leaf

0.02

Litsea guatemalensis Mez

Lauraceae

Laurel

Leaf

0.20

Mangifera indica L.

Anacardiaceae

Mango

Leaf

0.02
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Mentha piperita L.

Lamiaceae

Menthol Piperita

Aerial Portion

0.93

Mentha sp.

Lamiaceae

Hierba Buena

Aerial Portion

0.07

Murraya paniculata (L.) Jack

Rutaceae

Limonaria

Leaf

0.05

Myryca sp.

Myricaceae

Chiso

Leaf

0.21

Neurolaena lobata R.Br.

Asteraceae

Tres Puntas

Leaf

0.05

Ocimum basilicum L.

Lamiaceae

Albahaca

Aerial Portion

0.45

O. micranthum Willd.

Lamiaceae

Albahaca

Aerial Portion

0.15

Origanum vulgare L.

Lamiaceae

Oregano de Castillo

Leaf

1.05

Persea americana Mill.

Lauraceae

Aguacate

Leaf

0.03

Pimenta dioica (L.) Merr.

Myrtaceae

Pimienta

Leaf

0.26

Pinus maximinoi H.E.Moore 1

Pinaceae

Pino

Leaf

0.09

Piper auritum Kunth

Piperaceae

Santa Maria

Leaf

0.33

Pluchea odorata Cass.

Asteraceae

Siguapate

Leaf

0.03

Psidium guajava L.

Myrtaceae

Guayabo

Leaf

0.13

Rhus terebinthifolia Schltdl. & Cham. 1

Anacardiaceae

Sal de Venado

Leaf

0.03

Rosmarinus officinalis L.

Lamiaceae

Romero

Leaf

0.14

Ruta chalepensis L.

Rutaceae

Ruda

Aerial Portion

0.05
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Spilanthes americana Hieron. ex Sodiro

Asteraceae

Ixmaramac

Aerial Portion

0.09

Spondias purpurea L.

Anacardiaceae

Jocote

Leaf

0.01

Stevia connata Lag.

Asteraceae

Guapillo

Root

0.08

Stigmaphyllon ellipticum A.Juss. 1

Malpighiaceae

Contra Hierba

Leaf

< .01

Tagetes erecta L.

Asteraceae

Flor de Muerto

Aerial Portion

0.02

T. filifolia Lag.

Asteraceae

Anís de Monte

Aerial Portion

0.51

T. lucida Cav.

Asteraceae

Pericón

Aerial Portion

0.24

Teloxys ambrosioides (L.) W.A.Weber

Chenopodiaceae

Apasote

Aerial Portion

0.04

Thymus vulgaris L.

Lamiaceae

Tomillo

Aerial Portion

0.02

Verbena litoralis Kunth 1

Verbenaceae

Verbena

Aerial Portion

0.02

Vernonia leiocarpa DC. 1

Asteraceae

Suquenay

Leaf

0.11

Vetiveria zizanioides Nash

Poaceae

Valeriana

Root

0.03

Zingiber officinale Roscoe

Zingiberaceae

Jengibre

Rhizome

0.03

Sin Sin

Aerial Portion

0.36

Sin Sin2
1

Species not previously reported to have essential oil
Species not identified

2
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Table 2. MIC (ul/ml)1 and MIC range data (in parentheses) for essential oils from Guatemalan medicinal plants tested for
activity against microbial taxa
Species

E. coli

S. aureus

S. mutans

L. acidophillus

C. albicans

22

A. millefolium

NA

NA

1.46 (0.63 - 2.50)

3.75 (1.25 - 5.00)

2.50 (2.50)

Ageratum sp.

NT

NA

0.31 (0.31)

NT

NA

A. occidentale

NA

NT

NT

NT

NT

A. montana

NA

NA

2.71 (0.63 - 5.00)

NA

NA

B. latifolia

NA

NA

0.94 (0.31 - 1.25)

NT

NA

B. trinervis

NT

NA

IN

NT

NT

B. orellana

NA

NA

0.31 (0.31)

NA

NA

B. americana

NA

NA

0.63 (0.63)

NA

NA

B. davidii 2

NT

NT

NT

NT

NT

B. simaruba 2

NT

NT

NT

NT

NT

C. edulis 2

NT

NT

NT

NT

NT

C. zeylanicum

0.83 (0.63 - 1.25)

1.04 (0.63 - 1.25)

0.31 (0.31)

1.46 (0.63 - 2.50)

0.63 (0.31 - 1.25)

C. verticillata

NA

NA

0.31 (0.31)

NA

NA

C. donnell-smithii 2

NT

NT

NT

NT

NT

C. aurantiifolia

2.50 (1.25 - 5.00)

0.42 (0.31 - 0.63)

0.63 (0.63)

1.25 (1.25)

0.31 (0.31)

C. aurantium

NA

2.92 (1.25 - 5.00)

2.92 (1.25 - 5.00)

NT

0.42 (0.31 - 0.63)

22
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C. limetta

NA

3.33(2.50 - 5.00)

1.67 (1.25 - 2.50

4.16 (2.50 - 5.00)

0.42 (0.31 - 0.63)

C. dioica 2

NT

NT

NT

NT

NT

Croton sp.

NT

NT

IN

NT

NT

C. lusitanica

NA

NA

0.42 (0.31 - 0.63)

1.25 (1.25)

NA

C. citratus

IN

0.63 (0.31 - 1.25)

IN

IN

IN

E. spicatus

NT

NT

IN

NT

NT

Eucalyptus sp.

NA

5.00 (5.00)

2.50 (2.50)

1.25 (1.25)

5.00 (5.00)

E. semialatum

NA

NA

IN

NT

NT

F. vulgare

NA

NA

2.50 (2.50)

5.00 (5.00)

0.63 (0.63)

I. aquifolium

NT

NT

0.42 (0.31 - 0.63)

NT

NT

L. camara 2

NT

NT

NT

NT

NT

L. dulcis

NT

NT

IN

NA

NT

L. graveolens

0.31 (0.31)

0.31 (0.31)

0.31 (0.31)

0.83 (0.63 - 1.25)

0.31 (0.31)

L. styraciflua 2

NT

NT

NT

NT

NT

L. guatemalensis

NA

NA

0.31 (0.31)

2.08 (1.25 - 2.50)

NA

M. indica

NA

NT

NT

NT

NT

M. piperita

1.25 (1.25)

1.04 (0.63 - 1.25)

0.42 (0.31- 0.63)

1.67 (1.25 - 2.50)

1.04 (0.63 - 1.25)
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Mentha sp.

NT

IN

NT

NT

NT

M. paniculata

NT

NA

IN

NT

NT

Myryca sp.

NA

NA

0.31 (0.31)

NA

NA

N. lobata

NA

NT

NT

NT

NT

O. basilicum

NA

NA

NA

NA

NA

O. micranthum

NA

NA

0.42 (0.31 - 0.63)

2.92 (1.25-5.00)

NT

O. vulgare

0.31 (0.31)

0.31 (0.31)

0.31 (0.31)

1.04 (0.63 - 1.25)

0.31 (0.31)

P. americana

NT

NT

NA

NA

NT

P. dioica

NT

NT

0.42 (0.31 - 0.63)

0.83 (0.63 - 1.25)

NT

P. maximinoi

NA

NA

0.52 (0.31 - 0.63)

1.04 (0.63 - 1.25)

NA

P. auritum

NA

NA

2.08 (1.25 - 2.50)

2.08 (1.25 - 2.50)

0.83 (0.63 - 1.25)

P. odorata

NA

NA

0.31 (0.31)

NT

NT

P. guajava

NA

NA

0.42 (0.31 - 0.63)

NA

NA

R. terebinthifolia 2

NT

NT

NT

NT

NT

R. officinalis

NA

NA

0.52 (0.31 - 0.63)

2.08 (1.25 - 2.50)

NA

R. chalepensis

NA

NA

2.50 (2.50)

2.08 (1.25 - 2.50)

0.31 (0.31)

S. americana

NT

NT

IN

NT

NT

24
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S. purpurea 2

NT

NT

NT

NT

NT

S. connata

NA

NT

NT

NT

NT

S. ellipticum 2

NT

NT

NT

NT

NT

T. erecta

NT

NA

IN

NT

NT

T. filifolia

0.52(0.31 - 0.63)

NA

1.04 (0.63 - 1.25)

NA

0.52 (0.31 - 0.63)

T. lucida

0.31 (0.31)

4.17 (2.50 - 5.00)

NT

NT

NT

T. ambrosioides

NA

NA

NA

NA

0.63 (0.63)

T. vulgaris 2

NT

NT

NT

NT

NT

V. litoralis

NA

NA

NT

NT

NT

V. leiocarpa

NT

NA

NT

NT

NT

V. zizanioides

NT

NT

0.42 (0.31 - 0.63)

NT

NT

Z. officinale 2

NT

NT

NT

NT

NT

Sin Sin

NA

0.31 (0.31)

0.31 (0.31)

IN

NA

Gentamycin

2.50 (2.50)

0.83 (0.63 - 1.25)

0.83 (1.25-2.50)

3.33 (2.50 - 5.00)

NT

Nystatin

NT

NT

NT

NT

2.50 (2.50)

1

NA = activity not observed; NT = not tested on microbes; IN = activity observed but not enough oil for three replicates
Species not tested due to low oil yield

2
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Table 3. Family distribution of Guatemalan medicinal plant species containing essential oil, number of species producing an MIC
(ul/ml) against a microbe, and mean MIC values for species in a family
Family

No. of
sp.
with
oil

No. of
sp.
with
MIC

Sp.
with
MIC
(%)

No. of sp.
with
highly
inhibitory
MIC

Sp. with
highly
inhibitory
MIC (%)

X̄
family
MIC
against
E. coli

X̄
family
MIC
against
S.
aureus

X̄
family
MIC
against
S.
mutans

X̄ family
MIC
against L.
acidophillus

X̄
family
MIC
against
C.
albicans

5.00*

0.63*

3.75

1.51

26

Anacardiaceae

4

Apiaceae

1

1

100

2.50*

Aquifoliaceae

1

1

100

0.42*

Asteraceae

15

7

47

3

20

Bixaceae

1

1

100

1

100

Buddlejaceae

2

1

50

Burseraceae

1

Chenopodiaceae

1

1

100

Cupressaceae

1

1

100

Euphorbiaceae

1

Hamamelidaceae

1

Lamiaceae

7

4

57

1

14

0.78

Lauraceae

3

2

67

2

67

0.83*

0.42

4.17*

1.13
0.31*
0.63*

0.63*

26

0.42*

1.25*

0.68

0.42

1.93

0.68

1.04*

0.31

1.77

0.63*
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Malpighiaceae

1

Myricaceae

1

1

100

Myrtaceae

3

3

100

Pinaceae

1

1

Piperaceae

1

Poaceae

2

Ranunculaceae

1

Rutaceae

1

100

0.31*
5.00*

1.11

1.04

100

0.52*

1.04*

1

100

2.08*

2.08*

0.83*

2

100

6

4

67

2

33

Verbenaceae

5

1

20

1

20

Vitaceae

1

1

100

1

100

Zingiberaceae

1

*Not an average because value represents the results of only one species
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5.00*

0.63*

0.42*

2.50*

2.22

1.93

2.50

0.36

0.31*

0.31*

0.31*

0.83*

0.31*

0.31*

CHAPTER III
Essential Oils Obtained from 22 Guatemalan Medicinal Plants Evaluated in vitro
for Activity Against Cancerous and Established Cell Lines
Introduction
Essential oils are complex mixtures of chemicals, and include monoterpenes, sesquiterpenes and
phenolics (Carson & Riley, 1995). Their compositions are known to be unique among species of
the same family and often among tissues of an individual plant (Cates, 1996; Kalemba &
Kunicka, 2003; Bakkali et al., 2008). This uniqueness in essential oil composition is related to
both environmental and genetic factors (Valladares et al., 2002; Lahlou, 2004; Bakkali et al.,
2008; Hussain et al., 2008; Barra, 2009).

Essential oils are known to have biological activity against a variety of organisms (Edris, 2007),
including bacteria (Bakkali et al., 2008), fungi (Kalemba & Kunicka, 2003), protozoans (Boyom
et al., 2003; Anthony et al., 2005) and viruses (Edris, 2007). The effectiveness of whole essential
oils as well as individual components against cancer cell lines has also been demonstrated (Edris,
2007). Their activity has been shown to be a sum of the effects of the individual components
based on the ratio of the different constituents and not necessarily on the quantity of one
component (Kalemba & Kunicka, 2003; Houghton et al., 2007). This synergism indicates the
potential for individual oils to result in specific mechanisms of action toward a particular
organism or cancer cell line (Wittstock & Gershenzon, 2002; Rajesh & Howard, 2003; Savelev
et al., 2003; Salminen et al., 2008).
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The study reported here is part of a larger project aimed at gaining a better understanding of the
use of medicinal plants by rural Guatemalan villagers (Miller, 2010). Common traditional
preparations of medicinal plants involve teas which are created either by decoction or infusion,
and are known methods for the extraction of essential oils (Carnat et al., 1999; Bilia et al., 2000;
Radulescu et al., 2004). Preliminary screening of 141 medicinal plant species from Guatemala
yielded 44 species with sufficient essential oil content for microbial bioassays (Miller, 2010). Of
these 44 species, 22 were selected for this study and their activity against several cancer cell
lines and their level of cytoxicity are reported.

Materials and Methods
Plant selection and tissue collection
Plants from Guatemala were selected for this study based on quantity of essential oil yielded
from previous steam distillation extractions (Miller, 2010). All plants chosen are utilized by
Guatemalans in traditional medicine, although none of the plants are reported as traditional
treatments for cancer. Commonly used medicinal plants were collected in Guatemala from 2007
to 2009. Berny Danilo Gálvez and Carlos Enrique Ardón collected plants in the Chiquimula
Department in the villages of Tuticopote Abajo, Salitrón, and Roblarcito of the Torjá River
basin, and in San Francisco Chancó of the Chancó River basin in the municipalities of Olopa and
San Juan Ermita. Additional collections were made in Guatemala City by Dr. Ivan Rodríguez
and Rex Cates at the Museo Odontológico de Guatemala and the Jardín Botánico Maya, by Luis
Espinoza and R. Cates in the Pinalito association, and by Alfonso Fuentes and Dany Arbizu from
the medicinal plant gardens at the University of San Carlos, Guatemala City Guatemala.
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Each sample was individually numbered and bagged and placed in a cooler on dry ice. Voucher
specimens were collected and are stored in the Natural Products Laboratory at Brigham Young
University Provo, UT and the herbarium at the University of San Carlos, CUNORI Campus,
Chiquimula, Guatemala (Table 1). Collected samples were then stored in a freezer until shipped
on dry ice to the Natural Products Laboratory in Provo, Utah and stored at -80o C until analyzed.
Tissue types varied between leaf, seed and aerial portions to whole plants. Species were
identified by the taxonomists Jose Vicente Martínez Arvevalo, Mario Esteban Véliz Perez, and
Marco Romilio Estrada Muy using voucher specimens and in some instances, vouchers and
digital photographs.
Essential oil extraction and preparation
A steam distillation apparatus (Scientific-Glass, Rancho Santa Fe, CA, USA) was used to extract
essential oils (Luque de Castro, 1999). In order to determine the general chemical content of
these extracts, preliminary samples were extracted and analyzed by GC-MS (HP model
6890/5973, Agilent Technologies Inc., Santa Clara, CA, USA). Commonly found in these
extracts were monoterpenes, diterpenes, sesquiterpenes and other volatile compounds routinely
extracted by steam distillation. Prior to distillation, fresh plant tissue was weighed and cut into ½
inch sized pieces. 50g of tissue was used for each extraction and steam distillation was conducted
at 315o C for 3½ hours. Seed samples were first ground in liquid nitrogen using 125g of tissue
followed by steam distillation at 315o C for 8 hours.

After extraction, oil was pipetted from the receiver without the assistance of any additional
solvents. All oils were immediately dehydrated with anhydrous sodium sulfate (EMD Chemicals
Inc., Darmstadt, Germany), weighed and stored in amber vials at -80o C until tested.
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Cell lines and cytotoxicity
Three cancer cell lines AGS (Stomach, ATCC CRL-1739; ATCC, Manassas, VA, USA), A375
(Skin, ATCC CRL-161; ATCC) and CAL27 (Tongue, ATCC CRL-2095; ATCC) were chosen
for testing of bioactivity. An establish cell line from Monkey Kidney cells, Vero C 1008 (ATCC
CRL-1586; ATCC), was chosen to determine cytotoxicity of the essential oils and for calculating
a therapeutic index.

A375, CAL27 and Vero C 1008 cell lines were grown in DMEM (GIBCO, Grand Island, NY,
USA) fortified with 10% Fetal Bovine Serum (FBS) (ATCC), 5ml of 1M HEPES (Hyclone,
Logan, UT, USA), 2.5ml of 100mM sodium pyruvate (Hyclone) and 5ml of 10mg/ml
gentamycin (Sigma-Aldrich, St. Louis, MO, USA). Cells were grown to 90% confluency in
75cm2 flasks (Sarstedt, Newton, NC, USA) and then seeded into 96-well plates (Sarstedt). AGS
cells were grown in Ham’s F-12 Kaighn’s Modification media (Hyclone) fortified with FBS
(10%), 5ml of 1M HEPES and 5ml of 10mg/ml gentamycin. Cells were grown to 90%
confluency in 175cm2 flasks (Sarstedt).
Method adaptation
Assessment of the bioactivity of essential oils can be problematic, due to the highly volatile
nature of the oils and their lack of solubility (Donaldson et al., 2005). Volatile components were
found to cross-contaminate adjacent wells of 96-well plates (Donaldson et al., 2005) even at low
concentrations, thereby leading to inaccurate estimations of Minimum Inhibitory Concentration
(MIC) and IC50 values.
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Donaldson et al. (2005) proposed the addition of 2% biological grade agar (w/v) (Remmal et al.,
1993) to the culture media to remedy this problem in microbial tube dilution assays. In order to
adapt the method of Donaldson et al. (2005) to allow the use of 96-well plates, 15% biological
grade agar (v/v) was added to the cell culture media. The addition of 15% agar (v/v) mixed with
cell culture media was consistently shown to have no inhibitory effects on the growth of
untreated cells in preliminary trials, and the resulting mixture of inert agar maintained a stable
emulsion over a 24 hour period and minimized oil volatility.
Cell culture techniques
DMEM agar-media was prepared by adding melted molecular biology grade agar (Fisher, Fair
Lawn, NJ, USA) to incomplete media at a 15% v/v ratio at room temperature, and the mixture
was allowed to cool. FBS (10%) was then added followed by 5ml of 1M HEPES, 2.5ml of
100mM sodium pyruvate and 5ml of 10mg/ml gentamycin. Ham’s F-12 Kaighn’s Modification
agar-media was prepared in the same manner with the omission of sodium pyruvate.

Cells were seeded in 96-well plates and incubated for 24 hours in order to reach 90% confluency.
AGS cells were seeded at a density of 7.0 x 104, A375 at 6.0 x 104, CAL27 at 5.0 x 104 and Vero
C 1008 at 2.0 x 104. Each well was filled with 150μl of complete media and then placed in an
incubator with a 5% CO2 atmosphere.

Seeded plates were removed from the incubator after 24 hours and the media removed. Plate
design allowed for two essential oils and controls to be tested on each plate in three replications.
Essential oils were serially diluted in agar-media resulting in final concentrations of 7.0μl/ml,
3.5μl/ml, 1.75μl/ml, 0.88μl/ml, 0.44μl/ml, 0.22μl/ml, 0.11μl/ml and 0.05μl/ml. 200μl of diluted
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essential oil was then added to each well. Controls consisted of 200μl of agar-media in wells
with no additives. All edge wells remained unseeded and were filled with 200μl of sterilized
distilled water (DDH2O). Each plate was returned to the incubator for an additional 24 hours.
Determination of IC50 and CC50
The Neutral Red (NR) assay was chosen for the determination of IC50 and CC50 because it is a
commonly used assay that is sensitive and accurate in the quantitative assessment of in vitro
cytotoxicity (Borenfreund & Peuner, 1985; Babich & Borenfreund, 1991; Schröterová et al.,
2009). Plates were removed from the incubator after 24 hours, and the agar-media with oil was
discarded. Phosphate buffered saline (PBS) was used to gently wash and remove all traces of the
essential oil and the agar-media from the wells. NR dye solution was made using 0.33mg/ml NR
solution (3-aminom-dimethylamino-2-methyl-phenazine hydrochloride in DBPS) (SigmaAldrich) and then added to complete media to make a 10% NR media mixture. This solution was
added to each well excluding edge wells which were filled with sterilized DDH2O. Plates were
then incubated for three additional hours after which the NR media mixture was removed and
discarded. A fixative solution (1% CaCl2; Fisher in 0.5% formaldehyde; Mallinckrodt,
Phillipsburg, NJ, USA) was added and then removed after 30 seconds of exposure. This was
followed by the addition of a solublization solution (1% acetic acid; EM Science, Gibbstown,
NJ, USA, in 50% ethanol; Decon Labs, King of Prussia, PA, USA). Each plate was gently
agitated for 10 minutes on a shaker table after which cell viability was measured using a Fusion
α-HT Universal Microplate Analyzer (Packard Instruments, Meriden, CT, USA) with a 540 nm
filter and a 690 nm reference filter (Babich and Borenfreund, 1991).
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Final reading values were generated by subtracting the 690 values from the 540 values followed
by correction of the data by subtracting the average value generated from the blank edge wells.
The values of three replicate trials were averaged and then graphed using Fathom Dynamic
Statistics (Finzer et al., 2001) to determine final IC50 and CC50 values. A Therapeutic Index was
calculated using the ratio CC50/ IC50 (Greer et al., 2010).

Results
Essential oil yield
Oil yield from steam distillation indicates that 13 species produced a yield of 0.25% or less,
seven species between 0.25 - 0.5% and two species greater than 0.5% (Table 1). The families
Asteraceae, Lamiaceae, Myrtaceae, Lauraceae and Rutaceae were represented by multiple
species. Yield data shows that oils from Rutaceae consistently yielded 0.25% or less while the
other families produced yields with more variation. Single extractions of individual species
produced enough oil for all assays to be performed. All species used in this study come from
families known to produce oils (Lahlou, 2004; Bakkali et al., 2008), although Pinus maximinoi
and Buddleja americana have not been previously reported to have essential oils (Miller, 2010).
IC50 and CC50
All oils assayed showed inhibitory activity against one or more cancer cell lines (Table 2).
Highly inhibitory IC50 values of 0.10μl/ml or less were observed against cancer cell lines in eight
instances from four species (12% of total recorded IC50). Additionally, 28 moderately inhibitory
IC50 values (between 0.10μl/ml and 0.30μl/ml) were observed from 15 species (42% of total
recorded IC50), with a total of 36 instances of an IC50 of 0.30μl/ml or less. In total, ten IC50 values
(45%) for the A375 line, 12 IC50 values (54%) for the AGS line and 14 IC50 values (64%) for the
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CAL27 line were below 0.3μl/ml. The calculation of the average IC50 of each cell line shows the
CAL27 line having the most inhibitory average IC50 with 0.29μl/ml, followed by AGS at
0.32μl/ml and A375 at 0.49μl/ml.

Highly inhibitory IC50 values of 0.10μl/ml or less were produced by oils from Citrus
aurantiifolia (3), Origanum vulgare (2), Teloxys ambrosioides (2) and Lippia graveolens (1). All
values from C. aurantiifolia were less than 0.05μl/ml, which was the smallest measurable IC50
value able to be assessed in this assay. Oils from C. aurantiifolia, T. ambrosioides, L.
graveolens, O. vulgare and Pinus maximinoi were the most inhibitory to the CAL27 line. A375
cells were most effectively inhibited by C. aurantiifolia, T. ambrosioides, O. vulgare, L.
graveolens and Cinnamomum zeylanicum, and AGS was most inhibited by C. aurantiifolia,
Citrus limetta, L. graveolens, Psidium guajava, and Eucalyptus sp.

All essential oils were shown to be cytotoxic to the Vero C 1008 cell line at some concentration
(Table 2). Ten oils (45%) produced highly cytotoxic CC50 values of 0.10μl/ml or less and nine
oils (41%) produced moderately inhibitory CC50 values (between 0.10μl/ml and 0.30μl/ml). In
total, 19 oils (86%) produced a CC50 value below 0.30μl/ml against the Vero C 1008 cells. The
most cytotoxic CC50 values were produced by the oils of Cupressus lusitanica, Citrus
aurantiifolia, Bixa orellana, Buddleja americana, and Teloxys ambrosioides.

The calculation of the Therapeutic Index (TI) resulted in 14 incidences (21%) where the TI value
was greater than 1, indicating higher cytotoxcity to cancer cells over cells from the established
cell line (Table 3). All three recorded TI values for Ruta chalepensis were over 1, two values
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over 1 were recorded for Citrus limetta, Citrus aurantium, Rosmarinus officinalis and Origanum
vulgare and one value over 1 was recorded for Eucalyptus sp., Pinus maximinoi and Lippia
graveolens. Ten TI values were unable to be calculated due to IC50 or CC50 values below the
smallest measurable value able to be assessed in this assay (Table 3)..

Discussion
IC50 and CC50
Many of the essential oils used in this study have not previously been tested against human
cancer cell lines in vitro (Table 2). The IC50 values produced here indicate the first known
reporting of their activity against cancer cell lines. All of the oils used showed some inhibitory
effect on the cancer cells lines (Table 2) and many displayed high inhibition at low
concentrations, which is a good evaluator to determine which extracts should be selected for
additional research and testing. Citrus aurantiifolia was the most effective oil against all three
cancer cell lines with an IC50 below 0.05μl/ml for each line (Table 2). Oil from Origanum
vulgare produced highly inhibitory IC50 values against the A375 and the CAL27 cell lines and
Lippia graveolens produced a highly inhibitory IC50 value against the CAL27 line. The
calculated average IC50 for both oils is 0.12μl/ml, indicating potential for broad scale cancer cell
inhibition. Both oils have been reported to have similar composition, providing an explanation
for their comparable levels of activity (Salgueiro et al., 2003). Oil from Teloxys ambrosioides
also produced two highly inhibitory IC50 values against A375 and CAL27 but the value against
AGS was significantly less inhibitory, which suggests more potential for line specific activity.
Additional oils with average IC50 values of moderate inhibition are Litsea guatemalensis,
Cinnamomum zeylanicum and Psidium guajava with values of 0.19μl/ml, 0.20μl/ml and
0.21μl/ml, respectively.
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Results of the TI calculation indicate that a number of oils used in this study show potential
based on their relative level of cytotoxicty to cells from the established cell line (Table 3). The TI
values of Citrus limetta, Citrus aurantium, Lippia graveolens and Origanum vulgare indicate the
potential of these oils against the CAL27 line. Additionally TI values of C. limetta, C. aurantium
and Eucalyptus sp. indicate potential against the AGS line while oils of O. vulgare and
Rosmarinus officinalis showed similar results towards the A375 line.

The oil from Ruta chalepensis was the only oil that generated three TI values greater than 1,
although none of the individual IC50 values were highly inhibitory and the average IC50 was
0.62μl/ml. This oil shows potential for additional testing and identification of active components
to determine if similar compounds are active against both non-cancerous and cancerous cells.
Average TI values of 2.05 and 1.52 were calculated for C. limetta and C. aurantium against
CAL27 and AGS, respectively, possibly indicating broad spectrum activity. O. vulgare showed a
similar result against the CAL27 and A375 lines with an average TI of 1.18. This result is
significant due to the relatively high average IC50 required to effectively inhibit skin cancer cells
throughout this study.

Conclusion
The aims of this study were to provide more understanding about medicinal plants commonly
used in Guatemala. Essential oils seem to be found in a large number of these plants and may
play a role in their effectiveness. This study has demonstrated an improved method for
evaluating the effects of essential oils on cancer cell lines used for in vitro screenings. Results
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have also shown that essential oils can be highly effective against a variety of cancer cell lines in
vitro with oils from Citrus aurantiifolia, Origanum vulgare, Teloxys ambrosioides and Lippia
graveolens showing potential for future development. Additional results of the Therapeutic
Indices indicate that essential oils can be more toxic to cancerous cells than to cells from the
established cell line, with Citrus limetta, Citrus aurantium, L. graveolens, O. vulgare,
Eucalyptus sp, Rosmarinus officinalis and Ruta chalepensis showing broad and line-specific
potential for development.

Additional tests are needed to determine the extent of effectiveness of these essential oils. Active
compounds need to be isolated and tested for their specific levels of cytotoxicity to cancerous
and non-cancerous cells. The cancer cell lines used in this study are particular as potential
cancers that could be treated directly with essential oils. In vivo studies need to be conducted to
determine how living organisms metabolize the components of essential oils presented directly in
a whole or fractionated form.

The search for new and more effective drugs for cancer should include essential oils as
resources. With various methods of action and with a wide variety of compounds found naturally
in unique combinations, essential oils show much potential in the development of new drugs and
functional products.
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Table 1. Species, family, common name, tissue type and percent yield per species for Guatemalan medicinal plants extracted by
steam distillation
Species

Family

Common Name

Tissue

% Yield (w/w)
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Achillea millefolium L.

Asteraceae

Milenrama

Aerial Portion

0.11

Bixa orellana L.

Bixaceae

Achiote

Seed

0.12

Buddleja americana L.

Buddlejaceae

Salvia Santa

Leaf

0.09

Cinnamomum zeylanicum Blume

Lauraceae

Canela

Leaf

0.45

Citrus aurantiifolia (Christm.) Swingle

Rutaceae

Limón Criollo

Leaf

0.25

C. aurantium L.

Rutaceae

Naranja

Leaf

0.08

C. limetta Risso

Rutaceae

Lima

Leaf

0.17

Cupressus lusitanica Mill.

Cupressaceae

Ciprés

Leaf

0.93

Eucalyptus sp.

Myrtaceae

Eucalipto

Leaf

0.35

Foeniculum vulgare Mill.

Apiaceae

Hinojo

Aerial Portion

0.07

Lippia graveolens Kunth

Verbenaceae

Oregano

Aerial Portion

0.45

Litsea guatemalensis Mez

Lauraceae

Laurel

Leaf

0.24

Mentha piperita L.

Lamiaceae

Menthol Piperita

Aerial Portion

0.50

Ocimum basilicum L.

Lamiaceae

Albahaca

Aerial Portion

0.33

Origanum vulgare L.

Lamiaceae

Oregano de Castillo

Aerial Portion

0.66
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Table 1. cont.
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Pinus maximinoi H.E.Moore

Pinaceae

Pino

Leaf

0.04

Piper auritum Kunth

Piperaceae

Santa Maria

Leaf

0.27

Psidium guajava L.

Myrtaceae

Guayabo

Leaf

0.19

Rosmarinus officinalis L.

Lamiaceae

Romero

Leaf

0.23

Ruta chalepensis L.

Rutaceae

Ruda

Aerial Portion

0.07

Tagetes filifolia Lag.

Asteraceae

Anís de Monte

Aerial Portion

0.50

Teloxys ambrosioides (L.) W.A.Weber

Chenopodiaceae

Apasote

Aerial Portion

0.12
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Table 2: IC50 values (ul/ml) for essential oils of Guatemalan medicinal plants tested for
activity on cancerous and established cell lines in vitro
Species

Vero C

CAL27

A375

AGS

A. millefolium 1

0.2

0.28

0.29

0.4

B. orellana 1

<.05*

0.79

0.65

0.29

B. americana 1

0.06

0.27

0.44

0.39

C. zeylanicum

0.08

0.16

0.18

0.25

C. aurantiifolia

<.05*

<.05*

<.05*

<.05*

C. aurantium 1

0.25

0.16

0.37

0.17

C. limetta 1

0.31

0.18

0.62

0.13

C. lusitanica 1

<.05*

0.22

0.25

0.36

Eucalyptus sp.

0.17

0.32

0.38

0.16

F. vulgare 1

0.3

0.42

0.64

0.87

L. graveolens 1

0.09

0.07

0.14

0.15

L. guatemalensis 1

0.11

0.17

0.2

0.19

M. piperita

0.09

0.23

0.4

0.35

O. basilicum

0.14

0.34

0.36

0.39

O. vulgare

0.1

0.08

0.09

0.18

P. maximinoi 1

0.15

0.15

0.6

0.17

P. auritum 1

0.17

0.43

0.86

0.41

P. guajava

0.07

0.21

0.28

0.15

R. officinalis

0.26

0.41

0.24

0.21

R. chalepensis 1

0.72

0.51

0.71

0.64

T. filifolia 1

0.42

0.7

2.6

>7**
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Table 2. cont.
T. ambrosioides 1

0.06

0.07

1

0.08

Oils not previously reported to have been tested on cancer cell lines in vitro
*IC50 values are below the measurable values of this assay
**IC50 values are above the measurable values of this assay
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0.66

Table 3: Therapeutic Index values for essential oils of Guatemalan medicinal plants
tested for activity on cancerous and established cell lines in vitro
Species

CAL27

A375

AGS

A. millefolium

0.71

0.69

0.50

B. orellana

†

†

†

B. americana

0.22

0.14

0.15

C. zeylanicum

0.50

0.44

0.32

C. aurantiifolia

†

†

†

C. aurantium

1.56

0.68

1.47

C. limetta

1.72

0.50

2.38

C. lusitanica

†

†

†

Eucalyptus sp.

0.53

0.45

1.06

F. vulgare

0.71

0.47

0.34

L. graveolens

1.29

0.64

0.60

L. guatemalensis

0.65

0.55

0.58

M. piperita

0.39

0.23

0.26

O. basilicum

0.41

0.39

0.36

O. vulgare

1.25

1.11

0.56

P. maximinoi

1.00

0.25

0.88

P. auritum

0.40

0.20

0.41

P. guajava

0.33

0.25

0.47

R. officinalis

0.63

1.08

1.24

R. chalepensis

1.41

1.01

1.13

T. filifolia

0.60

0.16

†
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T. ambrosioides

0.86

0.75

†TI unable to calculate due to lack of IC50 or CC50 value
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0.09

